VR: Bridging The Employment Gap For Americans With Disabilities
Paul Toomey is the President of Geographic Solutions. He's an expert in labor market data, workforce development and unemployment insurance.
getty
Nealy one in four adults in the United States reported having a disability in 2022, according to the Centers for Disease Control. Despite representing a significant portion of the population, individuals with disabilities face disproportionate challenges in securing employment opportunities. As of April 2025, the unemployment rate for people with a disability (8.2%) was twice as high as those with no disability (3.6%), according to the Bureau of Labor Statistics (BLS).
Vocational Rehabilitation (VR) programs play a crucial, yet often overlooked, role in helping individuals with disabilities overcome barriers to employment. As the American workforce continues to evolve amid technological advancements and shifting economic landscapes, VR programs can serve as an important bridge connecting skilled workers with meaningful employment opportunities. They also offer a strategic approach to expanding labor force participation while also creating pathways to economic independence for millions of Americans with disabilities.
The Rehabilitation Act of 1973 and its subsequent amendments, including significant expansions through the Workforce Innovation and Opportunity Act (WIOA), established the framework for today's VR programs. These landmark legislations aim to empower individuals with disabilities to find gainful employment, become economically self-sufficient and contribute to their local communities and economies.
The scope of VR services is intentionally broad to address the diverse needs of individuals with physical, cognitive or mental health disabilities. These services can include career counseling, skills training, career placement, post-employment support and workplace accommodation. However, the importance of VR extends beyond assisting individuals with disabilities in finding jobs. It plays a pivotal role in fostering a more inclusive and equitable society by helping to break down barriers that have historically excluded individuals with disabilities from the workforce.
According to the BLS' latest report, only 22.2% of Americans with disabilities are currently participating in the workforce, compared to 65.6% of individuals without a disability. Bridging this gap and creating new pathways for people with disabilities not only has the potential to transform an individual's life, but can also provide significant benefits to businesses and the U.S. economy as a whole.
If businesses actively participated in hiring individuals with disabilities, they would have access to a talent pool of millions of skilled, highly motivated workers. A 2023 Accenture study found that companies that actively embrace disability inclusion see nearly double the revenue and 2.6 times more net income. Researchers also found that these companies are 25% more likely to outperform in terms of productivity compared to their industry peers that don't prioritize inclusion.
Additionally, studies have shown that individuals with disabilities are great problem solvers and tend to have lower absenteeism rates. They also report high job satisfaction, which can lead to lower employee turnover and higher returns on investments in training and development.
The future of VR programs is being driven by technological advancements, changing societal attitudes and a deeper understanding of disability inclusion. To effectively tailor VR services to the unique needs, preferences and goals of each individual, many state agencies and businesses are exploring assistive technology and digital tools to provide greater accessibility. This includes the integration of AI into specialized software and other adaptive tools.
AI-powered tools can assist with job matching, skills assessment and personalized training. AI also has the potential to streamline case management processes, enhance client services and improve employment outcomes for people with disabilities. However, human oversight is still recommended to combat potential bias.
The rise of remote work opportunities has also opened new doors for individuals with disabilities, providing them with greater flexibility, accessibility and savings in commuting time and expenses. Building on the lessons learned from flexible work arrangements, state agencies have adjusted their VR services to offer training for individuals to learn digital skills, remote communication tools and effective strategies for working from home. I believe businesses can do the same.
VR plays a crucial role in fostering a more inclusive and economically vibrant society and workforce. VR programs can not only empower individuals with disabilities to secure meaningful employment, but they also provide them with valuable skills, resources and support to help them achieve financial independence. These services also unlock an untapped and highly motivated talent pool for businesses.
As technology and changing societal attitudes continue to reshape the employment landscape, it is crucial that we continue to invest in programs that eliminate barriers to employment, bridge the persistent employment gap and cultivate a society that acknowledges the unique potential of an individual with a disability.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
22 minutes ago
- New York Post
Boeing 787 Dreamliner jet in Air India crash was subject of conspiracy theories about dead whistleblower — and battery problems
Thursday's Air India plane crash that killed more than 240 people has brought renewed scrutiny on Boeing's 787 Dreamliner aircraft — which was at the center of a conspiracy theory following a whistleblower's suicide last year. The disaster marks the first time a 787 Dreamliner — Boeing's newest plane model — has been involved in a catastrophic crash since its debut in 2011. It's also the latest disaster to hit the beleaguered American aerospace giant — which has been dogged by a door that blew off a 737 jet, a leaky spacecraft that stranded astronauts on the International Space Station for months, as well as politically damaging delays in outfitting the new Air Force One jets. The Dreamliner is Boeing's bestselling wide-body aircraft, and more than 1,200 have been delivered to airlines worldwide. Advertisement The deadly crash has left a stain on the jet's safety record heading into the Paris air show next week. Boeing's stock tanking by nearly 4.8% as CEO Kelly Ortberg scrambles to boost production of the Dreamliner. 6 A Boeing 787 Dreamliner operated by Air India crashed and exploded on Thursday morning, killing more than 240 people. Viral Press via Reuters Connect 6 First responders work at the site of the plane crash in Ahmedabad, India. Saurabh Sirohiya/NurPhoto/Shutterstock The Dreamliner was first introduced on Japan's All Nippon Airways in 2011 and there are more than 30 operated by Air India today, according to Cirium, an aviation data firm. Advertisement The Air India jet that crashed on Thursday was built in 2014 and had performed some 8,000 takeoffs and landings, according to the Wall Street Journal. Despite enjoying a 14-year safety streak, the troubled aerospace giant has seen its Dreamliner suffer from a series of production woes and attention from whistleblowers warning about the massive plane's assembly. The issues began in 2013, with Boeing's fleet of 787s grounded following a series of battery fires flagged by air safety inspectors. Advertisement Boeing was also forced to pause all 787 deliveries for nearly two years until the summer of 2022 over quality concern issues. 6 Debris of the doomed Air India plane hands over the destroyed ceiling of a local building. REUTERS 6 The tragedy is the biggest aircraft disaster in India in nearly three decades. Saurabh Sirohiya/NurPhoto/Shutterstock The pause ended when the Federal Aviation Administration approved Boeing's plan to make fixes that included filling paper-thin gaps around the plane and replacing parts that were not made with the approved titanium needed. Advertisement Things only got worse for Boeing last year when whistleblowers began coming out, accusing the company of taking shortcuts to fill the gap created by the 2020 pause, with the former employees and engineers warning that the practice could cause premature damage to the planes. Boeing has repeatedly disputed the claims made by the whistleblower, claiming an internal investigation recovered no evidence to support the whistleblowers' concerns over the South Carolina factory where the Dreamliners are made. 6 Mourners gather in Patna to pray for the victims of the plane crash, were only one passenger reportedly survived. AFP via Getty Images 6 Boeing has more than 1,000 787-9 Dreamliners in operation around the world. Getty Images Among the whistleblowers was John Barnett, 62, who was found dead just a day after sitting for a deposition with the company's lawyers in March 2024. His death was ruled a suicide. Barnett's death triggered countless conspiracy theories targeted against Boeing, despite investigators finding no evidence of foul play involved in the former employee's death. Thursday's crash also comes as Boeing is still reeling from the deadly accidents involving its 737 Max plane, which saw 346 people die in crashes in 2018 and 2019. Advertisement The company had reached a deal with the Department of Justice last month to avoid taking criminal responsibility for the crashes. 'Our deepest condolences go out to the loved ones of the passengers and crew on board Air India Flight 171, as well as everyone affected in Ahmedabad,' Ortberg said in a statement following Thursday's tragedy.
Newsweek
27 minutes ago
- Newsweek
Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Senator Bernie Sanders is leading a new bill to address a key priority of Robert F. Kennedy Jr., who serves as President Donald Trump's Health and Human Services Secretary. Why It Matters Sanders, a Vermont independent, alongside Senator Angus King, a Maine independent, introduced the "End Prescription Drug Ads Now Act," which, if passed, would ban prescription drug advertising on TV, radio, print and digital platforms as well as social media. Critics say these ads contribute to the high price of healthcare while doing little to improve care in the United States, though proponents say the advertisements can improve patients' knowledge of healthcare. Most wealthy countries, with the U.S. and New Zealand being two notable exceptions, ban pharmaceutical drug advertisements. The bill also represents an issue where Sanders, viewed as perhaps the most progressive senator, has found common ground with Kennedy inside the Trump administration, though the secretary has not commented on this bill specifically. What to Know Sanders and King announced the legislation on Thursday, highlighting that the pharmaceutical industry spent more than $5 billion on TV ads in 2024 and that many of these drugs cost more in the U.S. than in other countries that do not allow drug companies to run ads on TV. "The American people are sick and tired of greedy pharmaceutical companies spending billions of dollars on absurd TV commercials pushing their outrageously expensive prescription drugs," Sanders said, describing the fact that the U.S. stands mostly alone in allowing pharmaceutical ads as an "international embarrassment." vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, D.C. vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, director of communications Anna Bahr confirmed to Newsweek his office has reached out to Republicans to join the bill. Bahr pointed to lobbying from the pharmaceutical and health insurance industries as to why the U.S. has not joined other countries in bannign the ads. "Over the past 25 years, the drug companies have spent $8.5 billion on lobbying. Today, they have some 1,800 well-paid lobbyists in Washington, D.C. – including former leaders of the Republican and Democratic parties," she said in a statement to Newsweek. "Unbelievably, that is more than three lobbyists for every member of Congress. During that same period, they have provided over $700 million in campaign contributions. And they are equal opportunity contributors. They contribute heavily to both Republican and Democratic candidates." Secretary Kennedy—as well as Elon Musk, who previously served in Trump's administration—have expressed support for ending pharmaceutical advertising. "Let's get President Trump back in the White House and me to DC so we can ban pharmaceutical advertising," Kennedy wrote in a post to X (formerly Twitter) on November 3, 2024. During his own presidential campaign, Kennedy said he would have issued an executive order ending the advertisements on his first day in office. Newsweek reached out to DHS for comment via the department's press contact form. Caleb Alexander, professor of epidemiology at the Johns Hopkins University Bloomberg School of Public Health, told Newsweek that while a potential ban's impact on drug prices remains uunclear, there would be benefits to ending these advertisements. Pharmaceutical advertisements can drive up "inappropriate demand" for prescription drugs in settings where they may not be needed, he said. "In terms of the potential benefits of banning [direct-to-consumer advertisements], the most immediate and likely is that it would temper demand for products in settings where they may not be needed," Alexander said. The U.S. has "evolved to believe" the benefits of the ads, such as empowering patients to identify health concerns, outweigh the risks, though much of the research on the topic indicates that the benefits may not be worth the drawbacks, he said. What People Are Saying Alexander told Newsweek: "Direct to consumer advertising has been a lightning rod for controversy, and it remains a curious and unique feature of the U.S. marketplace. While a ban on direct advertising may be welcomed by many, it's not going to fundamentally transform the marketplace for prescription drugs in the United States, simply because DTCA is highly concentrated among a small number of products. It may be a reasonable political and public health target, but I think that if you just look at the way the dollars flow, there's vastly more money spent on marketing drugs to prescribers." Senator Angus King wrote in a statement: "The widespread use of direct-to-consumer advertising by pharmaceutical companies drives up costs and doesn't necessarily make patients healthier. The End Prescription Drug Ads Now Act would prohibit direct-to-consumer advertising of pharmaceutical drugs to protect people. This bill is a great step to ensure that patients are getting the best information possible and from the right source: their providers and not biased advertisements." Elon Musk wrote to X in November 2024: "No advertising for pharma." What Happens Next It's unclear whether a majority of senators are also in support of the bill. So far, Democratic Senators Chris Murphy of Connecticut, Peter Welch of Vermont, Jeff Merkley of Oregon and Dick Durbin of Illinois have co-sponsored the bill, according to Sanders' office.
Yahoo
31 minutes ago
- Yahoo
US lawmakers pass tougher penalties for fentanyl traffickers
The US Congress on Thursday passed a bill imposing harsher penalties on fentanyl traffickers, with lawmakers from both parties anxious to crack down on an opioid that has driven an epidemic of deadly overdoses. The Senate-passed bill -- which delivers on a key election pledge of President Donald Trump to get tough on drug smuggling -- was rubber-stamped by the House on a 321-104 vote, with Democrats providing all but one of the no votes. The Justice Department says 75,000 Americans die each year because of fentanyl, making it the number one cause of death for people between the ages of 18 and 34 in the United States. The synthetic opioid is more potent than heroin and much cheaper to produce. "More Americans die of drug overdoses each year than the number of Americans who died in the entirety of the Vietnam War," Republican Senate Majority Leader John Thune said ahead of the vote. The HALT Fentanyl Act places copycat variations of fentanyl -- often sold by traffickers -- on the government's list of most dangerous "Schedule 1" drugs alongside the original substance. Lab-created fentanyl alternatives were reclassified to "Schedule 1" on a temporary basis seven years ago but the vote makes the change permanent. Trump has made halting the flow of fentanyl one of his priorities, even announcing it as a justification for import tariffs on Mexico and Canada. But opponents said the new law -- rather than tackling overdoses -- would simply repeat the mistakes of the so-called "War on Drugs." The Leadership Conference on Civil and Human Rights, a coalition of more than 240 US rights organizations, said in a statement the measure would "exacerbate pretrial detention, mass incarceration, and racial disparities in the prison system." "Beginning in the 1980s, draconian drug laws with harsh mandatory minimums and their resulting enforcement under the banner of the 'war on drugs' fueled skyrocketing prison populations," it said. ft/acb
